Since the PI3K/Akt signaling pathway represents a key pathway not only in BC development but also in its therapy resistance, we selected the Akt protein and its functional form phosphorylated at serine 473 (Akt-P-Ser473), in short pAkt, as key analytes. This evidence concerns the gene PIK3CA and breast cancer.